Redica Systems

How Can Medical Device Manufacturers Prepare for the EU MDR?

March 30, 2021

Conference Spotlight

Facility Inspections Among FY2020 CVM Accomplishments

March 25, 2021

Trends

Part II: An Analysis Of MHRA’s Latest Annual GMP Inspection Deficiencies Report

March 24, 2021

On-Demand Webinar | QMS for Small Pharma and Biotech Firms

March 22, 2021

Trends

Part I: An Analysis Of MHRA’s Latest Annual GMP Inspection Deficiencies Report

March 17, 2021

Conference Spotlight

Update on US/EU MRA: Inspection Reports Being Exchanged

March 16, 2021

Conference Spotlight

PIC/S GMP Inspection Reliance Guidance Helps Global Agencies During Pandemic

March 11, 2021

Conference Spotlight

Redica Systems Senior GMP Quality Expert Jerry Chapman to Present at PDA Annual

March 10, 2021

One Year Since COVID-19: A Roundup

March 4, 2021

Conference Spotlight

Onsite Pharma FDA Inspections During COVID-19 Respect State Restrictions

March 3, 2021

Conference Spotlight

Desk Inspections, Missed Action Dates Take Place of FDA In-Person Site Visits

February 25, 2021

Enforcement

FDA Issues 38-Page 483 to Solid Oral Dosage Manufacturer

February 23, 2021

Conference Spotlight

FDA Chooses Not to Perform Virtual Inspections in Contrast with Non-U.S. Agencies

February 18, 2021

(Video) A 21st Century Solution for Regulated Industries

February 16, 2021

Conference Spotlight

Impact of the EU MDR on Combination Product Sale and Registration in the EU

February 11, 2021

Surveying the Smart Combination Product Ecosystem

February 9, 2021

An Analysis of 2015 to 2019 FDA 483 Data

January 28, 2021

What is Enforcement Analytics?

January 26, 2021